trazbull, they don't have 20 days because you didn't factor 30 days from the beginning of the month from the brokerage So they have both sitting on their backs and the brokerage doesn't care about NASDAQ's 20 days, they need their money tomorrow !

~70,000,000 shares need to be covered by tomorrow!

According to my calculations,
If we gave $ENTB a 100,000,000 volume hit today and tomorrow we could be talking about going from .0015 to .01 in 1-2 days!! It ran up 36.36% on just 14 million volume to .0015 yesterday with 100 million shorted since January 1st http://otcshortreport.com/entb

Comparatively, it took 115 million in volume to reach 36.36% above .0024 in $BMSN yesterday to .0033 with a total of ~250 million volume yesterday and 1 BILLION shares in total needed to be covered by the end of month (EOM) with a 130 million short volume conducted yesterday equating to approximately 51% of the volume. The last time this spiked to the 50% and above range was on Jan 9th, with 53.36% short volume two days before a ~400% run. If you look at the short history there was a VERY clear upward spike yesterday which indicates that we will be seeing another 400% run before EOM (TOMORROW) http://otcshortreport.com/bmsn Noting that most brokerage houses require a short position to be closed MAXIMUM within 30 days from the beginning of the month, that expiration date would be TOMORROW and being generous and assuming 30% of the average short volume was covered that would leave us with ~698,000,000 shares that have to be covered by end of day (EOD) tomorrow, which equates to about ~2.8x the volume yesterday.. ARE YOU LISTENING FOLKS? We are talking unbelievable amounts of short covering having to be closed out of their accounts by EOD tomorrow. My friends, this is about to EXPLODE! If you look at my previous posts below you will see I was completely correct about the 1-2 day short covering from being on the SHO list. We might see (4x.0044=.017 by TOMORROW!)

--------------------------------------------

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=83941334

Weekend DD Summary for $BMSN (read inside):

#1 On Friday January 25th, 2013 $BMSN was announced to be on NASDAQ's regulatory SHO list as an officially shorted stock where significant short positions had failed to deliver shares for an overextended period of time http://www.nasdaqtrader.com/Trader.aspx?id=RegSHOThreshold This tells us a massive amount of shares have been shorted and if those shares are not covered within the next couple days there will be SEVERE and IMMEDIATE financial obligations which the brokerage houses holding those accounts will be forced to pay. Have you ever heard of a brokerage house paying your bills on a bad trade--nope. Therefore these shares MUST be covered within the next couple days which will cause a significant surge in share price.
#2 On Saturday January 26th, 2013 http://otcshortreport.com , a very popular short report website listed $BMSN as being shorted by over 1 BILLION SHARES.. yes 1,000,000,000 since January 1st http://otcshortreport.com/bmsn
#3 Just yesterday, on Sunday January 27th, 2013 news had spread to ihub that BTNSR, a subsidiary run off of Sierra World Equity Review announced a Price Target of $1.55 for $BMSN's IND by the summer time just a day before http://biotechnewsstockreview.blogspot.com/2013/01/bio-matrix-scientific-group-bmsn-price.html

--------------------------------------------

Saturday, January 26, 2013
Bio-Matrix Scientific Group (BMSN) Price Target $1.55 By Summer_Investigational New Drug Application (IND) For HemaXellerate Turning Big Pharma Heads Forecasts Biotech News Stock Review
Bio-Matrix Scientific Group (BMSN) Price Target $1.55 By Summer_Investigational New Drug Application (IND) For HemaXellerate Turning Big Pharma Heads Forecasts Biotech News Stock Review.
Adam feels that BMSN could quite possible become the stock of the year. Look for an epic run to begin after the filing of the IND and not stop until summer when the share price will hit $1.55. Lots of people are going to get rich off the back of BMSN.

About Biotech News Stock Review

Adam and Johnny both love investing in biotech stocks, especially small companies that have promising drug pipelines. Adam is an avid researcher and very meticulous in his stock selections, Adam previously worked for Sierra World Equity Review where he was fundamental in helping select numerous accurate FDA calls. Adam has a law degree from Yale and is also fluent in Mandarin which he studied at the University of Beijing.
Johnny is a executive for a large pharmaceutical company based in New Jersey, with years of experience in his position as Managing Director for mergers and acquisitions with with special focus on China, Johnny brings valuable insight and perspective to the blogs daily stock posts.
If you enjoy buying and selling stocks, occasionally trade stocks online and enjoy the thrill of seeing your stock breakout after positive FDA trial results, then perhaps you may enjoy our blog! To maintain impartiality we never hold positions in any of the stocks we blog about.
Posted by Sierra World Equity Review at 10:44 PM

--------------------------------------------

In conclusion with a pending short squeeze, IND, and news/financials to be released by end of this week we are looking at a MASSIVE increase in share price to take place. This will last into the next 3-4 months with many ups and downs but a consistent uptrend at least to $0.50 A measly $2,000 investment at .003 will become $333,333 at .50

--------------------------------------------

OS SHARES LAST FILED
AS OF OCT 23,2012
OUTSTANDING 323M

REGEN BIOPHARMA, INC.
A Bio-Matrix wholly owned subsidiary,

Regen BioPharma has assessed over 20,000 stem cell related issued patents, narrowed down to 2000 patents with commercial applicability, and further identified 30 patents available for licensing. The company seeks to inlicense, take the product to, and through clinical safety and efficacy "signal" and spin out technologies.

WHY STEM CELL TRANPLANTS ARE UNSUCCESSFUL...STEM CELLS DIE AFTER A WEEK.
Method for enhancing hematopoiesis
Patent #6,821,513

--------------------------------------------

What will you be doing with your massive gains? Write me back or PM me. I will most likely be taking a long vacation to Jamaica/Brazil/Switzerland/Caribbean Cruise And don't forget to follow me http://investorshub.advfn.com/boards/profilea.aspx?user=373707

--------------------------------------------

(EOM)

~698,000,000 shares need covered by tomorrow! (read inside)

At this point ALL SHORT ACCOUNTS since January 1st, 2013 are NEGATIVE over .0037, we're talking MILLIONS OF DOLLARS!

According to my calculations,
Comparatively, it took 115 million in volume to reach 36.36% above .0024 in $BMSN yesterday to .0033 with a total of ~250 million volume yesterday and 1 BILLION shares in total needed to be covered by the end of month (EOM) with a 130 million short volume conducted yesterday equating to approximately 51% of the volume. The last time this spiked to the 50% and above range was on Jan 9th, with 53.36% short volume two days before a ~400% run. If you look at the short history there was a VERY clear upward spike yesterday which indicates that we will be seeing another 400% run before EOM (TOMORROW) http://otcshortreport.com/bmsn Noting that most brokerage houses require a short position to be closed MAXIMUM within 30 days from the beginning of the month, that expiration date would be TOMORROW and being generous and assuming 30% of the average short volume was covered that would leave us with ~698,000,000 shares that have to be covered by end of day (EOD) tomorrow, which equates to about ~2.8x the volume yesterday.. ARE YOU LISTENING FOLKS? We are talking unbelievable amounts of short covering having to be closed out of their accounts by EOD tomorrow. My friends, this is about to EXPLODE! If you look at my previous posts below you will see I was completely correct about the 1-2 day short covering from being on the SHO list. We might see (4x.0044=.017 by TOMORROW!)

Now imagine if we took just 10% of our profits and gave $ENTB a 100,000,000 volume hit today and tomorrow?! It ran up its 36.36%
on just 14 million volume to .0015 with 100 million shorted since January 1st http://otcshortreport.com/entb We could be talking about going from .0015 to .01 in 1-2 days!

--------------------------------------------

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=83941334

Weekend DD Summary for $BMSN (read inside):

#1 On Friday January 25th, 2013 $BMSN was announced to be on NASDAQ's regulatory SHO list as an officially shorted stock where significant short positions had failed to deliver shares for an overextended period of time http://www.nasdaqtrader.com/Trader.aspx?id=RegSHOThreshold This tells us a massive amount of shares have been shorted and if those shares are not covered within the next couple days there will be SEVERE and IMMEDIATE financial obligations which the brokerage houses holding those accounts will be forced to pay. Have you ever heard of a brokerage house paying your bills on a bad trade--nope. Therefore these shares MUST be covered within the next couple days which will cause a significant surge in share price.
#2 On Saturday January 26th, 2013 http://otcshortreport.com , a very popular short report website listed $BMSN as being shorted by over 1 BILLION SHARES.. yes 1,000,000,000 since January 1st http://otcshortreport.com/bmsn
#3 Just yesterday, on Sunday January 27th, 2013 news had spread to ihub that BTNSR, a subsidiary run off of Sierra World Equity Review announced a Price Target of $1.55 for $BMSN's IND by the summer time just a day before http://biotechnewsstockreview.blogspot.com/2013/01/bio-matrix-scientific-group-bmsn-price.html

--------------------------------------------

Saturday, January 26, 2013
Bio-Matrix Scientific Group (BMSN) Price Target $1.55 By Summer_Investigational New Drug Application (IND) For HemaXellerate Turning Big Pharma Heads Forecasts Biotech News Stock Review
Bio-Matrix Scientific Group (BMSN) Price Target $1.55 By Summer_Investigational New Drug Application (IND) For HemaXellerate Turning Big Pharma Heads Forecasts Biotech News Stock Review.
Adam feels that BMSN could quite possible become the stock of the year. Look for an epic run to begin after the filing of the IND and not stop until summer when the share price will hit $1.55. Lots of people are going to get rich off the back of BMSN.

About Biotech News Stock Review

Adam and Johnny both love investing in biotech stocks, especially small companies that have promising drug pipelines. Adam is an avid researcher and very meticulous in his stock selections, Adam previously worked for Sierra World Equity Review where he was fundamental in helping select numerous accurate FDA calls. Adam has a law degree from Yale and is also fluent in Mandarin which he studied at the University of Beijing.
Johnny is a executive for a large pharmaceutical company based in New Jersey, with years of experience in his position as Managing Director for mergers and acquisitions with with special focus on China, Johnny brings valuable insight and perspective to the blogs daily stock posts.
If you enjoy buying and selling stocks, occasionally trade stocks online and enjoy the thrill of seeing your stock breakout after positive FDA trial results, then perhaps you may enjoy our blog! To maintain impartiality we never hold positions in any of the stocks we blog about.
Posted by Sierra World Equity Review at 10:44 PM

--------------------------------------------

In conclusion with a pending short squeeze, IND, and news/financials to be released by end of this week we are looking at a MASSIVE increase in share price to take place. This will last into the next 3-4 months with many ups and downs but a consistent uptrend at least to $0.50 A measly $2,000 investment at .003 will become $333,333 at .50

--------------------------------------------

OS SHARES LAST FILED
AS OF OCT 23,2012
OUTSTANDING 323M

REGEN BIOPHARMA, INC.
A Bio-Matrix wholly owned subsidiary,

Regen BioPharma has assessed over 20,000 stem cell related issued patents, narrowed down to 2000 patents with commercial applicability, and further identified 30 patents available for licensing. The company seeks to inlicense, take the product to, and through clinical safety and efficacy "signal" and spin out technologies.

WHY STEM CELL TRANPLANTS ARE UNSUCCESSFUL...STEM CELLS DIE AFTER A WEEK.
Method for enhancing hematopoiesis
Patent #6,821,513

--------------------------------------------

What will you be doing with your massive gains? Write me back or PM me. I will most likely be taking a long vacation to Jamaica/Brazil/Switzerland/Caribbean Cruise And don't forget to follow me http://investorshub.advfn.com/boards/profilea.aspx?user=373707

--------------------------------------------

(EOM)

What did I tell you?! $BMSN/$ENTB SHORT SQUEEZE !

I only get 15 posts/day but I always use them to inform you of what's making money, duh ! Weeeeeeeeeeeeeeeee BOOM-TOWN has just begun!!! Talk to you again tomorrow guys !

Weekend DD Summary for $BMSN (read inside):

#1 On Friday January 25th, 2013 $BMSN was announced to be on NASDAQ's regulatory SHO list as an officially shorted stock where significant short positions had failed to deliver shares for an overextended period of time http://www.nasdaqtrader.com/Trader.aspx?id=RegSHOThreshold This tells us a massive amount of shares have been shorted and if those shares are not covered within the next couple days there will be SEVERE and IMMEDIATE financial obligations which the brokerage houses holding those accounts will be forced to pay. Have you ever heard of a brokerage house paying your bills on a bad trade--nope. Therefore these shares MUST be covered within the next couple days which will cause a significant surge in share price.
#2 On Saturday January 26th, 2013 http://otcshortreport.com , a very popular short report website listed $BMSN as being shorted by over 1 BILLION SHARES.. yes 1,000,000,000 since January 1st http://otcshortreport.com/bmsn
#3 Just yesterday, on Sunday January 27th, 2013 news had spread to ihub that BTNSR, a subsidiary run off of Sierra World Equity Review announced a Price Target of $1.55 for $BMSN's IND by the summer time just a day before http://biotechnewsstockreview.blogspot.com/2013/01/bio-matrix-scientific-group-bmsn-price.html

--------------------------------------------

Saturday, January 26, 2013
Bio-Matrix Scientific Group (BMSN) Price Target $1.55 By Summer_Investigational New Drug Application (IND) For HemaXellerate Turning Big Pharma Heads Forecasts Biotech News Stock Review
Bio-Matrix Scientific Group (BMSN) Price Target $1.55 By Summer_Investigational New Drug Application (IND) For HemaXellerate Turning Big Pharma Heads Forecasts Biotech News Stock Review.
Adam feels that BMSN could quite possible become the stock of the year. Look for an epic run to begin after the filing of the IND and not stop until summer when the share price will hit $1.55. Lots of people are going to get rich off the back of BMSN.

About Biotech News Stock Review

Adam and Johnny both love investing in biotech stocks, especially small companies that have promising drug pipelines. Adam is an avid researcher and very meticulous in his stock selections, Adam previously worked for Sierra World Equity Review where he was fundamental in helping select numerous accurate FDA calls. Adam has a law degree from Yale and is also fluent in Mandarin which he studied at the University of Beijing.
Johnny is a executive for a large pharmaceutical company based in New Jersey, with years of experience in his position as Managing Director for mergers and acquisitions with with special focus on China, Johnny brings valuable insight and perspective to the blogs daily stock posts.
If you enjoy buying and selling stocks, occasionally trade stocks online and enjoy the thrill of seeing your stock breakout after positive FDA trial results, then perhaps you may enjoy our blog! To maintain impartiality we never hold positions in any of the stocks we blog about.
Posted by Sierra World Equity Review at 10:44 PM


--------------------------------------------

In conclusion with a pending short squeeze, IND, and news/financials to be released by end of this week we are looking at a MASSIVE increase in share price to take place. This will last into the next 3-4 months with many ups and downs but a consistent uptrend at least to $0.50 A measly $2,000 investment at .003 will become $333,333 at .50


--------------------------------------------

OS SHARES LAST FILED
AS OF OCT 23,2012
OUTSTANDING 323M

REGEN BIOPHARMA, INC.
A Bio-Matrix wholly owned subsidiary,

Regen BioPharma has assessed over 20,000 stem cell related issued patents, narrowed down to 2000 patents with commercial applicability, and further identified 30 patents available for licensing. The company seeks to inlicense, take the product to, and through clinical safety and efficacy "signal" and spin out technologies.

WHY STEM CELL TRANPLANTS ARE UNSUCCESSFUL...STEM CELLS DIE AFTER A WEEK.
Method for enhancing hematopoiesis
Patent #6,821,513


--------------------------------------------

What will you be doing with your massive gains? Write me back or PM me. I will most likely be taking a long vacation to Jamaica/Brazil/Switzerland/Caribbean Cruise And don't forget to follow me http://investorshub.advfn.com/boards/profilea.aspx?user=373707

--------------------------------------------

(EOM)

OMG is sharky really here or am I dreaming ?! LOL you made me SO MUCH money last year on ICP* and a lot on NTE* this year (which I just cashed out handsomely on)! Check out $ENTB it's the brother/sister/hand-in-hand company with $BMSN and under the rader at the moment. I think both are going to pop but right now $ENTB is the safest one as it's only in the .001's and could pop past .002 today!

Playing it safe and selling my remaining shares here! Shorts might be in control here for a couple days but I will be back because sooner or later this is going to be on SHO list if my conclusions are correct!

Alert! Shorts covering @ $ENTB! Up over 20%..on..under..5mil..shares..traded! $BMSN go go go!!

.01 coming indeed! .0014 THINNING!!! Buys/Short-covering coming in!
And to think, we're still under .002 LOL! Wait until we hit .0025 resistance again and bust through that!

It feels so good to be right ! I hope more people follow and listen to me now http://investorshub.advfn.com/boards/profilea.aspx?user=373707 When I say it's going up I know what I'm talking about and the short squeeze was imminent! $ENTB about to be up a couple 100% with $BMSN! Shorts covering, people buying on the ask, $1.55 target price for $BMSN means $1.55 target price for us! http://biotechnewsstockreview.blogspot.com/2013/01/bio-matrix-scientific-group-bmsn-price.html Only a couple million on ask LMAO! We're about to SKY ROCKET HERE!

Hey buddy, nope $ENTB is not on hold just not a lot of people paying attention to it right now lol. That's why I'm alerting folks now because they always get mad when I come on the board celebrating when we're up 200% but then PM me and ask me why I never alerted them it was going to pop. #OWELL lol, they can't say that anymore because I alert every single one that's going to pop now. I am here to help people make gains and the sooner they realize that the better. I'm the most honest guy around here! $BMSN go baby go!!

$BMSN! TOLD YOU SO! $ENTB next on list! Don't miss out!

Alert! Short Squeeze in progress @ $BMSN!
Now you will understand what I meant when I said being on the SHO list will cause 200%+ gains here alone! http://www.nasdaqtrader.com/Trader.aspx?id=RegSHOThreshold
Plus with the IND we're looking at $1.55 price target by summer time:
http://biotechnewsstockreview.blogspot.com/2013/01/bio-matrix-scientific-group-bmsn-price.html
Make sure to follow me to know where the money's at! http://investorshub.advfn.com/boards/profilea.aspx?user=373707

$SWVI almost at $0.36 for an easy double! Then I'm out until it drops to .10/.07 for the final run! It's been great here folks!

$NEOM #FAIL lol... Laura/YA, stop selling already! #TripleZeroes
You're going to have to go up at least 40% today for me to believe anymore stories here folks!

Close today: 0.045 (+/- 0.007) I'm calling it now!

Patience, we'll be popping bottles like $NTE* soon! .. which umm btw I GUARANTEE YOU is going to do another 100% today. I will write everyone on this board a check for $10,000 if it doesn't.

L2 GOING CRAZY AGAIN!!! Another 100% HERE! Gap and run! Short squeeze is ON.COM!!! Go $NTEK!!!

It will be out by Friday.. no doubts about that. Fake wall on the ask and 7x as much on bid LMAO... these guys think they know what they're doing lol. BOOM-TOWN on the way! SHORT SQUEEZE SOMETIME THIS WEEK !

Took 80% off table. Hope another gap tomorrow! $NTEK Weeeeeeeeeeeee

Yessir it's due by Friday! BOOM-TOWN COMING !

$NEOM back in play!!! Let's take her to .01!!

ALERT! Shorts trying to cover! 14,000,000 shares on bid!

Sure you can have one too. Anyone else?

If we don't close .005+ by Friday I will write you a check for $10,000 Mark this post!

BOOM! $NTEK ANOTHER +40% -- UP 80% !!

THE BATTLE IS ON! Shorts scared for their lives!

$NTEK Weeeeeeeeeeeeeeeeeeeeeeeeeeee!!! Morning Gapper up 40%+!

$SWVI morning gapper.. WEEEEEEEEEEEEEEEEEEE !!!! Called it again:

$GMEC NEWS!!! 2012 Events and Movie Revenue Exceeds 2011

HONG KONG, Jan 28, 2013 (MARKETWIRE via COMTEX) -- Great China Mania Holdings, Inc., (OTCBB: GMEC) (the "Company" or "GMEC") announces its latest recapture of 2012 artist based events management and movie revenue has exceeded 2011. The total estimated revenue from such business segment amounts to $1.9 million, or an increase of 72% from $1.1 million as compared to 2011.

Some of the major revenue generating events in 2012 were:

McDonald Cafe Hong Kong TV commercial January 2012 in Hong Kong

Victoria Secret Macau opening February 9, 2012 China's First Victoria's Secret Store Opens at The Venetian Macao Glitzy and glamorous VIP cocktail event.

Alivenotdead.com x Sony XBA DJ Party March 4, 2012 alivenotdead.com x Sony XBA DJ Party in Hong Kong

Fanta star party DJ Show Sanya, Hainan Island April 21, 2012 Fanta Star Party with several famous artists

Taobao girls - model search 2012 Grand Finale Australia May 4, 2012 Grand Finale at Town Hall, Sydney Australia



CityLink TV commercial December 2012 Spokes girls of Hong Kong's largest electronics retailers

"All the above shortlisted events were revenue generating activities in 2012 with some of our reputable clients," Roy, CEO of GMEC, said. "Looking forward, we expect our artists based revenue in 2013 shall exceed 2012 to a minimum of $2.5 million."

About Great China Media Holdings, Inc.: GMEC (OTCBB: GMEC) is an electronic content provider that provides leisure and lifestyle-related electronic content through portal websites and major cell phone network operators. The Company also utilizes these electronic contents to produce traditional paper magazines. In order to support the provision of electronic contents, the Company operates an artist management company to leverage on the popularity of artists and celebrities in stories and event creations.

http://www.greatchinamania.com http://www.gmegroup.com.hk

Safe Harbor Statement Information in this document constitutes forward-looking statements or statements which may be deemed or construed to be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The words "forecast," "anticipate," "estimate," "project," "intend," "expect," "should," "believe," and similar expressions are intended to identify forward-looking statements. These forward-looking statements involve, and are subject to known and unknown risks, uncertainties and other factors which could cause Great China Mania Holdings' actual results, performance (financial or operating) or achievements to differ from the future results, performance (financial or operating) or achievements expressed or implied by such forward-looking statements. The risks, uncertainties and other factors are more fully discussed in Great China Mania Holdings' filings with the U.S. Securities and Exchange Commission. All forward-looking statements attributable to Great China Mania Holdings herein are expressly qualified in their entirety by the above-mentioned cautionary statement. Great China Mania Holdings disclaims any obligation to update forward-looking statements contained in this estimate, except as may be required by law.

Contact:

Great China Mania Holdings, Inc.
Tel : +852 2882 7026
Fax : +852 2882 7020

General Enquires:
Email Contact

Sales & Marketing:
Email Contact

Investor Relationship:
Email Contact


SOURCE: Great China Mania Holdings, Inc.

CONTACT: http://www2.marketwire.com/mw/emailprcntct?id=782AC0E6606C5847
http://www2.marketwire.com/mw/emailprcntct?id=49CF233F4AD6B244
http://www2.marketwire.com/mw/emailprcntct?id=814EC06CECE9E3DE

Copyright 2013 Marketwire, Inc., All rights reserved.

-0-

SUBJECT CODE: Computers and Software:Internet
Lifestyle and Leisure:Fashion
Lifestyle and Leisure:Recreation
Lifestyle and Leisure:Toys and Hobbies
Media and Entertainment:Information Services
Retail:E-Commerce
Media and Entertainment:Television
Professional Services:Advertising, PR and Marketing
Professional Services:Consulting
Retail:Consumer Electronics
Retail:Consumer Interest
Media and Entertainment:Music and Radio

L2 going bananas!!!! .106 x .11 $GMEC = GAP+RUN!!

Price target links: http://investorshub.advfn.com/boards/read_msg.aspx?message_id=83874419

Weekend DD Summary for $BMSN (read inside):

#1 On Friday January 25th, 2013 $BMSN was announced to be on NASDAQ's regulatory SHO list as an officially shorted stock where significant short positions had failed to deliver shares for an overextended period of time http://www.nasdaqtrader.com/Trader.aspx?id=RegSHOThreshold This tells us a massive amount of shares have been shorted and if those shares are not covered within the next couple days there will be SEVERE and IMMEDIATE financial obligations which the brokerage houses holding those accounts will be forced to pay. Have you ever heard of a brokerage house paying your bills on a bad trade--nope. Therefore these shares MUST be covered within the next couple days which will cause a significant surge in share price.
#2 On Saturday January 26th, 2013 http://otcshortreport.com , a very popular short report website listed $BMSN as being shorted by over 1 BILLION SHARES.. yes 1,000,000,000 since January 1st http://otcshortreport.com/bmsn
#3 Just yesterday, on Sunday January 27th, 2013 news had spread to ihub that BTNSR, a subsidiary run off of Sierra World Equity Review announced a Price Target of $1.55 for $BMSN's IND by the summer time just a day before http://biotechnewsstockreview.blogspot.com/2013/01/bio-matrix-scientific-group-bmsn-price.html

--------------------------------------------

Saturday, January 26, 2013
Bio-Matrix Scientific Group (BMSN) Price Target $1.55 By Summer_Investigational New Drug Application (IND) For HemaXellerate Turning Big Pharma Heads Forecasts Biotech News Stock Review
Bio-Matrix Scientific Group (BMSN) Price Target $1.55 By Summer_Investigational New Drug Application (IND) For HemaXellerate Turning Big Pharma Heads Forecasts Biotech News Stock Review.
Adam feels that BMSN could quite possible become the stock of the year. Look for an epic run to begin after the filing of the IND and not stop until summer when the share price will hit $1.55. Lots of people are going to get rich off the back of BMSN.

About Biotech News Stock Review

Adam and Johnny both love investing in biotech stocks, especially small companies that have promising drug pipelines. Adam is an avid researcher and very meticulous in his stock selections, Adam previously worked for Sierra World Equity Review where he was fundamental in helping select numerous accurate FDA calls. Adam has a law degree from Yale and is also fluent in Mandarin which he studied at the University of Beijing.
Johnny is a executive for a large pharmaceutical company based in New Jersey, with years of experience in his position as Managing Director for mergers and acquisitions with with special focus on China, Johnny brings valuable insight and perspective to the blogs daily stock posts.
If you enjoy buying and selling stocks, occasionally trade stocks online and enjoy the thrill of seeing your stock breakout after positive FDA trial results, then perhaps you may enjoy our blog! To maintain impartiality we never hold positions in any of the stocks we blog about.
Posted by Sierra World Equity Review at 10:44 PM


--------------------------------------------

In conclusion with a pending short squeeze, IND, and news/financials to be released by end of this week we are looking at a MASSIVE increase in share price to take place. This will last into the next 3-4 months with many ups and downs but a consistent uptrend at least to $0.50 A measly $2,000 investment at .003 will become $333,333 at .50


--------------------------------------------

OS SHARES LAST FILED
AS OF OCT 23,2012
OUTSTANDING 323M

REGEN BIOPHARMA, INC.
A Bio-Matrix wholly owned subsidiary,

Regen BioPharma has assessed over 20,000 stem cell related issued patents, narrowed down to 2000 patents with commercial applicability, and further identified 30 patents available for licensing. The company seeks to inlicense, take the product to, and through clinical safety and efficacy "signal" and spin out technologies.

WHY STEM CELL TRANPLANTS ARE UNSUCCESSFUL...STEM CELLS DIE AFTER A WEEK.
Method for enhancing hematopoiesis
Patent #6,821,513


--------------------------------------------

What will you be doing with your massive gains? Write me back or PM me. I will most likely be taking a long vacation to Jamaica/Brazil/Switzerland/Caribbean Cruise And don't forget to follow me http://investorshub.advfn.com/boards/profilea.aspx?user=373707

--------------------------------------------

(EOM)

If being on the SHO list over a 2 day weekend wasn't enough
http://www.nasdaqtrader.com/Trader.aspx?id=RegSHOThreshold then you don't even want to read below...

Bio-Matrix Scientific Group (BMSN) Price Target $1.55 By Summer_Investigational New Drug Application (IND) For HemaXellerate Turning Big Pharma Heads Forecasts Biotech News Stock Review
Bio-Matrix Scientific Group (BMSN) Price Target $1.55 By Summer_Investigational New Drug Application (IND) For HemaXellerate Turning Big Pharma Heads Forecasts Biotech News Stock Review.
Adam feels that BMSN could quite possible become the stock of the year. Look for an epic run to begin after the filing of the IND and not stop until summer when the share price will hit $1.55. Lots of people are going to get rich off the back of BMSN.

About Biotech News Stock Review

Adam and Johnny both love investing in biotech stocks, especially small companies that have promising drug pipelines. Adam is an avid researcher and very meticulous in his stock selections, Adam previously worked for Sierra World Equity Review where he was fundamental in helping select numerous accurate FDA calls. Adam has a law degree from Yale and is also fluent in Mandarin which he studied at the University of Beijing.
Johnny is a executive for a large pharmaceutical company based in New Jersey, with years of experience in his position as Managing Director for mergers and acquisitions with with special focus on China, Johnny brings valuable insight and perspective to the blogs daily stock posts.
If you enjoy buying and selling stocks, occasionally trade stocks online and enjoy the thrill of seeing your stock breakout after positive FDA trial results, then perhaps you may enjoy our blog! To maintain impartiality we never hold positions in any of the stocks we blog about.

BTNSR http://biotechnewsstockreview.blogspot.com/2013/01/bio-matrix-scientific-group-bmsn-price.html

THESE PRICES ARE GOING TO BE GONE TOMORROW! GAPPER!
This week will make any other gains previously made here look miniscule! Short squeeze BONANZA!

Happens a lot, just right place @ right time!

Thanks Teffy! We just keep picking all the winners!
$BMSN for duh win!
Don't forget:
http://www.nasdaqtrader.com/Trader.aspx?id=RegSHOThreshold
http://biotechnewsstockreview.blogspot.com/2013/01/bio-matrix-scientific-group-bmsn-price.html
http://otcshortreport.com/bmsn

SHO list + IND + Short Squeeze + $1.55 Target Price + Revolutionary Products + Mergers + News + Revenue + FDA + Stem Cells ... seriously, I'm running out of +'s here LOL! #BMSN

Why, are you going on a blind date lol?
After we hit $0.50 you'll have to beat the girls off you with a stick! "GET DOWN JESSICA! GET DOWN AMY! GET DOWN AMANDA!!! NO YOU CAN NOT ALL COME WITH ME ON MY SWEDISH VACATION!"

Mexico City with $300,000??? Pshh.. I'm going to Jamaica/Brazil/Switzerland/Caribbean!
I'll make sure to use the other $33,000 to leave for tips LOL! Might hold some for the ride to a dollar though and double some bucks!

Who reads it??? Same guys that called $AMB*! Did you not see what happened there? .003 to .16 in 3-4 months! HELLO DOLLARS! This is going to do the same thing by summer time as they stated BUT EVEN HIGHER:

http://biotechnewsstockreview.blogspot.com/2013/01/bio-matrix-scientific-group-bmsn-price.html

Saturday, January 26, 2013
Bio-Matrix Scientific Group (BMSN) Price Target $1.55 By Summer_Investigational New Drug Application (IND) For HemaXellerate Turning Big Pharma Heads Forecasts Biotech News Stock Review
Bio-Matrix Scientific Group (BMSN) Price Target $1.55 By Summer_Investigational New Drug Application (IND) For HemaXellerate Turning Big Pharma Heads Forecasts Biotech News Stock Review.
Adam feels that BMSN could quite possible become the stock of the year. Look for an epic run to begin after the filing of the IND and not stop until summer when the share price will hit $1.55. Lots of people are going to get rich off the back of BMSN.

About Biotech News Stock Review

Adam and Johnny both love investing in biotech stocks, especially small companies that have promising drug pipelines. Adam is an avid researcher and very meticulous in his stock selections, Adam previously worked for Sierra World Equity Review where he was fundamental in helping select numerous accurate FDA calls. Adam has a law degree from Yale and is also fluent in Mandarin which he studied at the University of Beijing.
Johnny is a executive for a large pharmaceutical company based in New Jersey, with years of experience in his position as Managing Director for mergers and acquisitions with with special focus on China, Johnny brings valuable insight and perspective to the blogs daily stock posts.
If you enjoy buying and selling stocks, occasionally trade stocks online and enjoy the thrill of seeing your stock breakout after positive FDA trial results, then perhaps you may enjoy our blog! To maintain impartiality we never hold positions in any of the stocks we blog about.
Posted by Sierra World Equity Review at 10:44 PM

Plus $BMSN being on the SHO list OVER a 2 day weekend!